Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in Borderline Personality Disorder
NCT00635921Phase 2Completed
- Sponsor
- Hospital de la Santa Creu i Sant Pau Research Institute
- Start
- Mar 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ziprasidone in borderline personality disorder (BPD), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Mar 2004; status: completed.
02
Drugs
ziprasidone
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on NCT00635921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635921.